Literature DB >> 25404632

Assessment of transverse abdominal muscle symmetry by ultrasonography.

Andrzej Myśliwiec1, Michał Kuszewski1, Edward Saulicz1, Paweł Linek1, Tomasz Wolny1, Małgorzata Białach1, Adam Posłuszny2.   

Abstract

BACKGROUND: One of the methods of assessing the transverse abdominal muscle is ultrasonography, which visualizes its thickness and location. We set out to answer the question if the transverse abdominal muscle can always be treated as located symmetrically among the trunk structures.
MATERIAL AND METHODS: A group of 113 volunteers took part in the study. The volunteers did not experience any severe pain of musculoskeletal structures as determined by the VAS and ODI scales. The location of the transverse abdominal muscle (TRA) was determined with a Honda NS 2100 ultrasound system. Basing on original methodology, the distance between the place where the transverse abdominal muscle tendon becomes the muscle belly and the linea alba was measured. The next stage was the assessment of correlation of pain.
RESULTS: The results in the study group show a statistically significant difference in the distance between the place where the transverse abdominal muscle tendon becomes the muscle belly and the linea alba between left and right. No correlation was found between the asymmetry and pain intensity.
CONCLUSIONS: 1. Differences in the distance between the transverse abdominal muscle and the linea alba on left and right side of the body were discovered in the study group. 2. No correlations were found between the presence of an asymmetry and lumbar pain in the study group.

Entities:  

Mesh:

Year:  2014        PMID: 25404632     DOI: 10.5604/15093492.1119620

Source DB:  PubMed          Journal:  Ortop Traumatol Rehabil        ISSN: 1509-3492


  1 in total

1.  A rehabilitation programme focussing on pelvic floor muscle training for persistent lumbopelvic pain after childbirth: A randomized controlled trial.

Authors:  Hui Wang; Xiaolan Feng; Zishu Liu; Yan Liu; Ribo Xiong
Journal:  J Rehabil Med       Date:  2021-04-12       Impact factor: 2.912

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.